期刊文献+

病人血浆中阿德福韦的浓度检测方法及耐药基因研究

Study on determination of Adefovir in Patients' Plasma and Drug Resistance Genes
下载PDF
导出
摘要 采用液质联用法测定血浆中阿德福韦药物浓度,并优化阿德福韦耐药基因检测方法。药物浓度测定:0.2 mL血浆中加入两倍体积的蛋白沉淀剂甲醇,高速离心后上清液吹干并用流动相甲醇-水(20︰80)溶解,应用电喷雾离子源的质谱检测;用套式PCR快速检测病人阿德福韦耐药突变。两种方法适用于临床样本检测,并可结合用于临床个体化治疗的研究。 To develop a rapid and easy to operating method for adefovir in plasma,and to optimize the method on identification of resistance genes,then to apply both methods on patients.Determination of drug concentration: The plasma samples were precipitated by methanol and centrifugated,the supernatants were volatilized by nitrogen and dissolved by mobile phase of methanol-water(20︰80).Electrospray ionization source was applied and operated in the positive ion mode.Adefovir resisitance mutations in patients were detected by nested PCR rapidly.The proposed method showed good linearity,repeatability and recovery,and with the method on drug resistance genes it can be applied to the study of individualized therapy.
出处 《药学与临床研究》 2011年第1期18-21,共4页 Pharmaceutical and Clinical Research
关键词 阿德福韦 液质联用 耐药突变 个体化治疗 Adefovir LC-MS/MS Resisitance mutations Individualized therapy
  • 相关文献

参考文献10

  • 1Tarrah W,Marlon H,Evans B,et al.Adefovir dipivoxil:a new agent for active hepatitis b virus infection[J].Drug Forecast,2003,28(1):31-4.
  • 2Benhamou Y,Bochet M,Calvez V,et al.Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus:an open-label pilot study[J].Lancet,2001,358(9):718-23.
  • 3蒋晔,徐智儒,张晓青.抗乙肝新药阿德福韦的研究进展[J].中国新药与临床杂志,2004,23(6):373-377. 被引量:62
  • 4Russell JW,Marrero D,Whiterock VJ,et al Determination of 9-[(2-phosphonylmethoxy)ethyl] adenine in rat urine by high-performance liquid chromatography with fluorescence detection[J].J Chromatogr B,1991,572(1-2):321-6.
  • 5Naesens L,Balzarini J,Clercq ED.Acyclic adenine nucleoside phosphonates in plasma determined by high performance liquid chromatography with fluorescence detection[J].Clin Chem,1 992,38(4):480-5.
  • 6Sparidans RW,Veldkamp A,Hoetelmans RMW,et al.Improved and simplified liquid chromatographic assay for adefovir,a novel antiviral drug,in human plasma using derivatization with chloroacetaldehyde[J].J Chromatogr B,1999,736(1-2):115-21.
  • 7Xiao Yc,Dan L,Lin Z,et al.Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of adefovir in human plasma[J].Rapid Commun Mass Spectrom,200S 19(13):1893-8.
  • 8Oliver S,Hueseyin S,Anneke E et al.Variant of hepatitis B virus with primary resistance to adefovir[J].N Eng J Med,2006,354(17):1807-12.
  • 9L6pez-Montenegro,Sofia MA,Kanter Berga J,et al.Genetic polymorphisms and individualized tacrolimus dosing[J].Transplant Proc,2010,42(8):3031-3.
  • 10Sugiyama E,Kaniwa N,Kim SR,et al.Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients:impact of genetic polymorphisms[J].Clin Pharmacokinet,2010,49(8):549-58.

二级参考文献22

  • 1PERRILLO R, SCHIFF E, YOSHIDA E, et al. Adefovir dipivolxil for the treatment of lamivudine-resistant hepatitis B mutants[J]. Hepatology, 2000, 32 (1): 129-134.
  • 2LAI CL, CHIEN RN, LEUNG NWY, et al. A one year trail of lamivudine for chronic hepatitis B[J]. N Engl J Med, 1998, 339(2) :61-68.
  • 3LAU DT, KHOKHAR F, DOO E, et al. Long-Term therapy of chronic hepatitis B with lamivudine [J]. Hepatology, 2000, 32(4):828-834.
  • 4BOCK CT, TILLMANN HL, TORRESI J. Selection of hepatitis B vires polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation [J]. Gastroenterology,2002, 122(2) :264-273.
  • 5XIONG X, YANG H, WESTLAND CE, et al. In vitro evaluation of hepatitis B vires polymerase mutations associated with famciclovir resistance[J]. Hepatology, 2000,31(1) :219-224.
  • 6WOLTERS LM, NIESTERS HG, Hansen BE, et al. Development of hepatitis B vires resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency vires in a Dutch cohort[J]. J Clin Virol, 2002,24(3):173-181.
  • 7XIONG X, FLORES C, YANG H, et al. Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro [J]. Hepatology, 1998, 28(6): 1669-1673.
  • 8NICHOLL AJ, COLLEDGE DL, TOOLE J J, et al. Inhibition of duck hepatitis B vires replication by 9-( 2-phosphonylmethoxyethyl) adenine, ana cyclic phosphonate nucleoside analogue[J]. Amimicrob Agents Chemother, 1998, 42(12): 3130-3135.
  • 9WOLTERS LM, NIESTERS HG, de MAN RA, et al. Nucleoside analogues for chronic hepatitis B [J]. Eur J Gastroenterol Hepatol, 2001, 13 (12): 1499-1506.
  • 10Le GUERHIER F, THERMET A, GUERRET S, et al. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model [J]. J Hepatol, 2003, 38(3) :328-334.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部